Biomarin Factor VIII Gene Transfer Results - The Fritsma Factor

Jan 21 2022

George Fritsma

Click here to see Biomarin’s 1-9-22 announcement of their 134-participant factor VIII gene transfer trial, valoctocogene roxaparvovec. Thanks to Dean Willett, Precision BioLogic Inc. for alerting us to this encouraging development.

Comments (0)

Bleeding Disorders

No comments here.

Leave a Reply Cancel reply

You must be logged in to post a comment.

George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question